Better medicines for children: clinical investigation of medicinal products in the paediatric population ‐ a QA perspective

Abstract

Currently the number of medicinal products labelled for paediatric use is limited. Clinical trials involving children are surely amongst the most challenging types of studies performed from a scientific, ethical and medical perspective. The article provides an outline of critical issues to be considered when developing drugs in this population. Copyright © 2008 John Wiley & Sons, Ltd.